Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00930657 · ClinicalTrials.gov registry record

CO2 Inhalation and Risk for Panic Disorder

A clinical trial, sponsored by National Institute of Mental Health (NIMH).

Terminated
Registry status
13
Enrollment target

NCT00930657: Clinical Trial study, sponsored by National Institute of Mental Health (NIMH).

NCT00930657 is a clinical trial that was terminated before completion, run by National Institute of Mental Health (NIMH). The registered enrollment target is 13 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00930657 was terminated before completion, sponsored by National Institute of Mental Health (NIMH).

TERMINATED
Registry status
13 participants
Enrollment target

Study Summary

Objective: To examine respiratory/physiological and subjective responding as well as genetic transmission among offspring of parents with a history of or current panic disorder (PD) diagnosis to determine whether diagnoses/symptoms, endophenotypes, or genetic profiles in offspring is differentially related to parent PD subtypes (i.e., respiratory and non-respiratory panic). Study population: Approximately 400 offspring of about 200 parents with current or past PD. Approximately 200 offsping/100 parents with PD will be enrolled at NIH/NIMH and the remainder at Virginia Commonwealth University in Richmond, VA. Design: A high-risk family design will be used wherein parents with either a current or past diagnosis of PD who have an offspring(s) (ages 9 to 20) will be recruited. \<TAB\> Outcome measures: Outcome measures will include physiological recordings of respiratory, cardiac, and electrodermal responding during a 10 minute baseline followed by 15 minutes of 5% carbon dioxide enriched air (CO2). Research participants also will complete parent and child self-report measures and provide a DNA sample using a saliva protocol. A full listing of self-reports is provided in the Outcome Measures Section.

Trial Details

FieldValue
Enrollment Target 13 participants
Start Date 2009-06-26
Est. Completion 2019-08-12

Why NCT00930657 stopped before completion

NCT00930657 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 13 participants, a relatively small participant target.

The record links to 0 conditions, and to 0 interventions.

NCT00930657 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00930657 about?

NCT00930657 is a clinical study titled "CO2 Inhalation and Risk for Panic Disorder". Objective: To examine respiratory/physiological and subjective responding as well as genetic transmission among offspring of parents with a history of or current panic disorder (PD) diagnosis to determine whether diagnoses/symptoms, endophenotypes, or genetic profiles in offspring is differentially...

What is the current status of trial NCT00930657?

This trial is currently terminated. The enrollment target is 13 participants. The study started on 2009-06-26. Estimated completion is 2019-08-12.

Who is sponsoring clinical trial NCT00930657?

This trial is sponsored by National Institute of Mental Health (NIMH), which has 343 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03125655 · 13 participants

    Regulation of Inflammatory Genes in Psoriasis

  • NCT03774446 · 13 participants · Phase 2

    Multicenter Study of Seliciclib (R-roscovitine) for Cushing Disease

  • NCT03830151 · 13 participants · Phase 1

    Hyperpolarized Carbon C 13 Pyruvate in Diagnosing Glioma in Patients With Brain Tumors

  • NCT04573231 · 13 participants · Phase 2

    Evaluation of PSMA in HER2- AR+ Metastatic Breast Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT00930657, the US trial registry maintained by the National Library of Medicine. NCT00930657 (small enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.